These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 31883873)

  • 1. Racial/ethnicity differences in endorsing influential factors for prostate cancer treatment choice: An analysis of data from the personal patient profile-prostate (P3P) I and II trials.
    Trinh QD; Hong F; Halpenny B; Epstein M; Berry DL
    Urol Oncol; 2020 Mar; 38(3):78.e7-78.e13. PubMed ID: 31883873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population.
    Suresh T; Sharma J; Goel S; Kovac E; Gao Q; Gartrell B
    Clin Genitourin Cancer; 2019 Apr; 17(2):139-144. PubMed ID: 30655076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
    Bassett MT; Chen JT; Krieger N
    PLoS Med; 2020 Oct; 17(10):e1003402. PubMed ID: 33079941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation.
    Kensler KH; Pernar CH; Mahal BA; Nguyen PL; Trinh QD; Kibel AS; Rebbeck TR
    J Natl Cancer Inst; 2021 Jun; 113(6):719-726. PubMed ID: 33146392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.
    Frego N; Labban M; Stone BV; Koelker M; Alkhatib K; Lughezzani G; Buffi NM; Lipsitz SR; Weissman JS; Fletcher SA; Kibel AS; Trinh QD; Cole AP
    Prostate; 2023 Aug; 83(11):1099-1111. PubMed ID: 37150867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database.
    Beckmeyer-Borowko AB; Peterson CE; Brewer KC; Otoo MA; Davis FG; Hoskins KF; Joslin CE
    Cancer Causes Control; 2016 Oct; 27(10):1261-71. PubMed ID: 27590306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.
    Bosco JL; Halpenny B; Berry DL
    Health Qual Life Outcomes; 2012 Sep; 10():123. PubMed ID: 23021156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in patterns of second primary malignancies across U.S. race and ethnicity groups: a Surveillance, Epidemiology, and End Results (SEER) analysis.
    McGuire V; Lichtensztajn DY; Tao L; Yang J; Clarke CA; Wu AH; Wilkens L; Glaser SL; Park SL; Cheng I
    Cancer Causes Control; 2024 May; 35(5):799-815. PubMed ID: 38206498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in Hispanic/Latino and non-Hispanic Black men with low-risk prostate cancer and eligible for active surveillance: a population-based study.
    Katz JE; Chinea FM; Patel VN; Balise RR; Venkatramani V; Gonzalgo ML; Ritch C; Pollack A; Parekh DJ; Punnen S
    Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):533-538. PubMed ID: 29988097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial disparities in post-stroke functional outcomes in young patients with ischemic stroke.
    Jones EM; Okpala M; Zhang X; Parsha K; Keser Z; Kim CY; Wang A; Okpala N; Jagolino A; Savitz SI; Sharrief AZ
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104987. PubMed ID: 32689593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insufficient Lycopene Intake Is Associated With High Risk of Prostate Cancer: A Cross-Sectional Study From the National Health and Nutrition Examination Survey (2003-2010).
    Lu Y; Edwards A; Chen Z; Tseng TS; Li M; Gonzalez GV; Zhang K
    Front Public Health; 2021; 9():792572. PubMed ID: 34966715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision support for men with prostate cancer: Concordance between treatment choice and tumor risk.
    Filson CP; Hong F; Xiong N; Pozzar R; Halpenny B; Berry DL
    Cancer; 2021 Jan; 127(2):203-208. PubMed ID: 33119142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and Ethnic Disparities in Functional Outcome after Thrombectomy: A Cohort Study of an Integrated Stroke Network.
    Jones E; Kumar A; Lopez-Rivera V; Sebaugh J; Kamal H; Sheth SA; Sharrief A; Zha A
    J Stroke Cerebrovasc Dis; 2021 Dec; 30(12):106131. PubMed ID: 34655973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in racial/ethnic disparities in patient care experiences between prostate cancer survivors and males without cancer: A SEER-CAHPS study.
    Pandit AA; Gressler LE; Halpern MT; Kamel M; Payakachat N; Li C
    J Geriatr Oncol; 2023 Jul; 14(6):101554. PubMed ID: 37320932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in patient-reported outcomes among men treated with radical prostatectomy for prostate cancer.
    Koelker M; Labban M; Frego N; Ye J; Lipsitz SR; Hubbell HT; Edelen M; Steele G; Salinas K; Meyer CP; Makanjuola J; Moore CM; Cole AP; Kibel AS; Trinh QD
    Prostate; 2024 Jan; 84(1):47-55. PubMed ID: 37710385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robot-Assisted Surgery and Racial and Ethnic Disparities in Post-Prostatectomy Outcomes Among Prostate Cancer Patients.
    Mao J; Genkinger JM; Rundle AG; Wright JD; Schymura MJ; Insaf TZ; Hu JC; Tehranifar P
    Ann Surg Oncol; 2024 Feb; 31(2):1373-1383. PubMed ID: 37880515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Influence of Ethnic Heterogeneity on Prostate Cancer Mortality After Radical Prostatectomy in Hispanic or Latino Men: A Population-based Analysis.
    Velasquez MC; Chinea FM; Kwon D; Prakash NS; Barboza MP; Gonzalgo ML; Ritch CR; Pollack A; Parekh DJ; Punnen S
    Urology; 2018 Jul; 117():108-114. PubMed ID: 29630954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis.
    Wilson LS; Blonquist TM; Hong F; Halpenny B; Wolpin S; Chang P; Filson CP; Master VA; Sanda MG; Chien GW; Jones RA; Krupski TL; Berry DL
    BMC Med Inform Decis Mak; 2019 Jan; 19(1):6. PubMed ID: 30626400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends in the utilization and outcome of transcatheter aortic valve replacement across racial and ethnic groups. A nationwide analysis.
    Antia A; Pius R; Ndukauba C; Zarauz VR; Olafiranye O
    Int J Cardiol; 2024 Mar; 399():131669. PubMed ID: 38141727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial/ethnic differences in the utilization of chemotherapy among stage I-III breast cancer patients, stratified by subtype: Findings from ten National Program of Cancer Registries states.
    Zhang L; King J; Wu XC; Hsieh MC; Chen VW; Yu Q; Fontham E; Loch M; Pollack LA; Ferguson T
    Cancer Epidemiol; 2019 Feb; 58():1-7. PubMed ID: 30415099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.